![]() |
市场调查报告书
商品编码
1316288
全球医疗器械 3D 打印市场 - 2023-2030 年Global Medical Device 3D Printing Market - 2023-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2022 年,全球医疗设备三维打印市场规模达到 26 亿美元,预计到 2030 年将实现利润丰厚的增长,达到 79 亿美元。在预测期内(2023-2030 年),全球医疗设备 3D 打印市场预计将呈现 15.7% 的复合年增长率。
3D 打印技术改变了假肢和矫形器的制造。这种技术可以制造出轻便、精确匹配的装置,使用户感觉更舒适、更有用。
外科医生可以利用 3D 打印技术制造出适合每位患者的手术指南和设备。这些手册有助于提高手术效果,降低手术风险,并帮助进行精确的术前准备。此外,还可以制作特殊工具,以满足特定的手术需求。
2023 年 6 月,EOS、Precision ADM、Orthopaedic Innovation Centre (OIC) 和 Tecomet 这四家医疗器械制造领域的公司建立了合作关系。此次合作将为医疗器械的增材制造提供全方位的解决方案。
要扩大增材制造医疗器械的规模,就必须全面了解整个流程链,其中不仅包括打印,还包括设计、后处理、测试、消毒和包装等。通过与 Tecomet、OIC 和 Precision ADM 的合作,我们将在增材制造领域积累无与伦比的经验,这将帮助医疗器械制造商克服监管环境中的困难,提供优质可靠的产品。
根据《3D 打印医学》杂志发表的文章,2022 年,美国食品和药物管理局(FDA)将通过现有的医疗器械法规对 3D 打印设备进行管制。然而,由于 3D 打印技术正在医疗保健行业迅速普及,FDA 越来越有兴趣制定专门针对护理点(PoC)3D 打印的标准和法规。
由于 3D 打印医疗设备研究的最新发展,医疗点 (PoC) 医疗设备的制造量迅速增加。尽管 PoC 3D 打印有可能提高患者的治疗效果并减少手术室的时间和费用,但这种设计和生产环境模糊了医疗设备制造商和治疗提供商之间的区别,并引发了监管方面的不确定性。
COVID-19 大流行对医疗器械 3D 打印市场产生了重大影响。由于 COVID-19 检测法规的出台,检测试剂盒和诊断工具的需求激增。鼻咽拭子和样本采集容器作为检测试剂盒和诊断工具的一部分,采用 3D 打印技术进行生产。利用 3D 打印技术,可以快速制作出这些组件的原型并进行生产,从而帮助满足日益增长的需求。
俄乌战争对医疗器械 3D 打印市场的影响是复杂和多方面的。在冲突期间,政府和医疗系统可能会优先考虑应急准备、基础设施和基本医疗需求。对医疗设备 3D 打印等尖端技术的接受和投资可能会受到这种优先级和资源分配变化的影响。更紧急、更直接的需求可能会得到资金和关注。
The global medical device 3D printing market reached US$ 2.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 7.9 billion by 2030. The global medical device 3D printing market is expected to exhibit a CAGR of 15.7% during the forecast period (2023-2030).
The manufacturing of artificial limbs and orthotic devices has been transformed by 3D printing. The technique makes it possible to create lightweight, precisely fitting devices that are comfier and useful for the user.
Surgeons can use 3D printing to make surgical guidance and equipment that are unique to each patient. These manuals help to improve surgical outcomes, lower surgical risks, and aid in precise pre-operative preparation. Additionally, special tools might be created to meet certain surgical needs.
In June 2023, EOS, Precision ADM, Orthopaedic Innovation Centre (OIC), and Tecomet, four companies operating in the medical device manufacturing sector, established cooperation. An all-inclusive solution for the additive manufacture of medical devices will be offered by this cooperation.
Scaling up the manufacturing of AM medical devices necessitates a thorough understanding of the entire process chain, which goes beyond printing and includes, among other things, design, post-processing, testing, sterilization, and packaging. Incomparable experience in additive manufacturing will result from our collaboration with Tecomet, OIC, and Precision ADM, which will assist medical device manufacturers in navigating the difficulties of the regulatory environment and supplying high-quality, dependable goods.
As per the article published in 3D Printing in Medicine, in 2022, through already-existing medical device rules, the Food & Drug Administration (FDA) of the United States controls 3D-printed devices. However, because 3D printing is spreading quickly throughout the healthcare industry, the FDA is becoming more and more interested in creating standards and regulations specifically for point-of-care (PoC) 3D printing.
Manufacturing of point-of-care (PoC) medical devices has rapidly increased as a result of recent developments in 3D-printed medical device research. Despite the fact that PoC 3D printing has the potential to enhance patient outcomes and cut down on operating room time and expenses, such a design and production environment blurs the distinction between medical device manufacturers and providers of treatment and raises regulatory uncertainty.
The COVID-19 pandemic has had a significant impact on the medical device 3D printing market. The demand for testing kits and diagnostic tools surged as a result of the COVID-19 testing regulations. Nasopharyngeal swabs and sample-collecting containers were produced using 3D printing as part of testing kits and diagnostic tools. Utilizing 3D printing, it was possible to quickly prototype and produce these components, helping to satisfy the growing demand.
The impact of the Russia-Ukraine war on the medical device 3D printing market is complex and multifaceted. Governments and healthcare systems may prioritize emergency preparedness, infrastructure, and essential healthcare requirements during times of conflict. The acceptance and investment in cutting-edge technologies like 3D printing for medical devices could be impacted by this change in priorities and resource allocation. More urgent and immediate demands may receive funding and attention.
The global medical device 3D printing market is segmented based on product, technology, application, end-user, and region.
The electron beam melting segment accounted for the highest market stake accounting for approximately 36.1% of the medical device 3D printing market in 2022. In the 3D manufacturing technique known as electron beam melting (EBM), a high-energy electron beam melts a metal powder. An object that precisely matches the criteria specified by a CAD model is created by melting multiple layers of powdered metal under the control of an electron beam, which generates an electron stream that is guided by a magnetic field.
In order to protect highly reactive materials from oxidation, production is done in a vacuum chamber. Similar to Selective Laser Melting (SLM), Electron Beam Melting (EBM) prints from a powder from the powder bed of the 3D printer, but EBM utilizes an electron beam as opposed to a laser.
North America is expected to dominate the Medical Device 3D Printing market, accounting for around 38.7% of this market. In March 2023, with a collaboration with 3D Systems, the manufacturer of medical devices Paragon Medical is investing in additive manufacturing capabilities. According to reports, the new cooperation will make use of the historical knowledge and competencies that both institutions can offer to clients.
The collaboration between the companies covers material procurement and supply, part design and process development, machine onboarding and validation, and regulatory assistance. The partnership between 3D Systems and Paragon Medical will enable them to grow the production of medical devices using cutting-edge metal and plastic 3D printing technology.
The major global players in the market include: Stratasys Ltd., EnvisionTEC, Koninklijke Philips N.V., 3D Systems, Inc., EOS, Renishaw plc, Materialise, 3T Additive Manufacturing Ltd., General Electric Company, Carbon, Inc., and Prodways Group among others.
The global medical device 3D printing market report would provide approximately 69 tables, 72 figures, and 195 Pages.
LIST NOT EXHAUSTIVE